SCHEMBL4141971

SCHEMBL4141971

CNc1ccc(SC(F)(F)F)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PTPN1 P18031 2/20 0.39
PTPRZ1 P23471 2/20 0.39
ESR1 P03372 1/20 0.37
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
KCNH2 Q12809 1/20 0.35
KCNK2 O95069 5/20 0.35
MEN1 O00255 1/20 0.34
ALOX15 P16050 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4142424 0.86 MEN1 (0.36) SMN1; SMN2ALDH1A1ESR1TSHRMAPK1
SCHEMBL4157937 0.83 ESR1 (0.34) SMN1; SMN2ESR1LMNATSHRMAPK1
SCHEMBL3625294 0.81 KDM4E (0.39) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL29543347 0.80 KDM4E (0.47) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL17382597 0.80 KDM4E (0.47) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL4142050 0.80 KDM4E (0.42) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL12828098 0.78 SMN1; SMN2 (0.51) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL14494197 0.77 SMN1; SMN2 (0.39) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL21766011 0.76 LMNA (0.49) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1
SCHEMBL21759166 0.76 LMNA (0.39) SMN1; SMN2KDM4EALDH1A1TDP1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 SMN1; SMN2 2011/4885KDM4E 1105/4885ALDH1A1 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.